LivaNova PLC (LIVN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LIVN SEC filings page.
LivaNova PLC (LIVN) reported $1.5B in revenue over the twelve months to Jun 30, 2026, up 12.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Operating profitability has improved sharply, but FY2025’s net loss shows that gains above operations are not reaching bottom-line earnings.
Revenue rose20.3% from FY2023 to FY2025 while operating profitability turned positive, showing that the cost base absorbed growth more efficiently. Gross margin remained around68% , so the improvement points more to operating-cost absorption than a major product-margin shift.
FY2025 operating cash flow reached
Debt-to-equity declined from 0.4x in FY2024 to 0.3x in FY2025, indicating lower debt leverage even as total equity fell. However, the current ratio dropped from 2.9x to 1.4x, showing that short-term liquidity narrowed while debt leverage improved.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of LivaNova PLC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
LivaNova PLC has an operating margin of 14.4%, meaning the company retains $14 of operating profit per $100 of revenue. This results in a moderate score of 48/100, indicating healthy but not exceptional operating efficiency. This is up from 10.3% the prior year.
LivaNova PLC's revenue grew 10.7% year-over-year to $1.4B, a solid pace of expansion. This earns a growth score of 64/100.
LivaNova PLC carries a low D/E ratio of 0.29, meaning only $0.29 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.
LivaNova PLC's current ratio of 1.36 indicates adequate short-term liquidity, earning a score of 36/100. The company can meet its near-term obligations, though with limited headroom.
LivaNova PLC converts 12.5% of revenue into free cash flow ($173.3M). This strong cash generation earns a score of 66/100.
LivaNova PLC posts a -20.2% return on equity (ROE), meaning it loses $20 for every $100 of shareholders' equity. This results in a returns score of 41/100. This is down from 4.8% the prior year.
LivaNova PLC scores 2.08, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($4.2B) relative to total liabilities ($1.4B). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
LivaNova PLC passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
LivaNova PLC reported a net loss of $242.5M while generating $254.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
LivaNova PLC earns $4.05 in operating income for every $1 of interest expense ($199.4M vs $49.3M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
LivaNova PLC generated $390.6M in revenue in Q2 2026. This represents an increase of 10.8% from the same quarter a year earlier. Against the prior quarter it is up 7.8%.
LivaNova PLC's EBITDA was $64.9M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 19.4%.
LivaNova PLC reported $108.6M in net income in Q2 2026. This represents an increase of 299.7% from the same quarter a year earlier. Against the prior quarter it is up 387.0%.
LivaNova PLC earned $1.93 per diluted share (EPS) in Q2 2026. This represents an increase of 286.0% from the same quarter a year earlier. Against the prior quarter it is up 382.5%.
Cash & Balance Sheet
LivaNova PLC generated $35.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 26.7% from the same quarter a year earlier. Against the prior quarter it is up 3683.8%.
LivaNova PLC held $516.6M in cash against $289.9M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
LivaNova PLC's gross margin was 70.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.
LivaNova PLC's operating margin was 12.7% in Q2 2026, reflecting core business profitability. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
LivaNova PLC's net profit margin was 27.8% in Q2 2026, showing the share of revenue converted to profit. This is up 20.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 21.7 percentage points.
LivaNova PLC's ROE was 8.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 5.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.3 percentage points.
Capital Allocation
LivaNova PLC invested $53.7M in research and development in Q2 2026. This represents an increase of 13.7% from the same quarter a year earlier. Against the prior quarter it is down 8.6%.
LivaNova PLC invested $31.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 108.3% from the same quarter a year earlier. Against the prior quarter it is up 120.8%.
Not reported for Q2 2026.
LIVN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $390.6M+10.8% | $362.3M+14.3% | $360.9M+12.1% | $357.8M+12.5% | $352.5M+10.7% | $316.9M+7.4% | $321.8M+3.8% | $318.1M+11.2% |
| Cost of Revenue | $116.9M+3.0% | $118.5M+17.8% | $121.1M+12.7% | $112.9M+16.3% | $113.5M+9.5% | $100.6M+9.7% | $107.5M-20.6% | $97.1M+15.2% |
| Gross Profit | $273.7M+14.5% | $243.7M+12.7% | $239.8M+11.9% | $244.9M+10.8% | $239.0M+11.2% | $216.3M+6.4% | $214.4M+22.7% | $221.0M+9.5% |
| R&D Expenses | $53.7M+13.7% | $58.7M+55.0% | $52.1M+20.4% | $48.6M-0.5% | $47.2M+5.5% | $37.9M-17.0% | $43.3M-6.2% | $48.8M+4.9% |
| SG&A Expenses | $158.1M+14.8% | $143.6M+11.2% | $143.4M+9.7% | $138.5M+8.7% | $137.8M+10.1% | $129.1M+2.8% | $130.6M+10.8% | $127.4M-5.5% |
| Operating Income | $49.5M-8.7% | $41.5M-14.7% | $42.6M+15.0% | $54.0M+51.6% | $54.2M+34.9% | $48.6M+199.3% | $37.0M+142.1% | $35.6M+699.0% |
| EBITDA | $64.9M-0.9% | $54.3M-8.3% | $54.6M+14.6% | $66.3M+43.4% | $65.5M+29.4% | $59.3M+120.7% | $47.7M+184.6% | $46.2M+320.0% |
| Interest Expense | $7.2M-51.9% | $8.3M-45.8% | $8.2M-48.0% | $10.9M-31.6% | $14.9M-3.9% | $15.3M-3.8% | $15.8M+0.9% | $15.9M+6.0% |
| Income Tax | -$90.2M-1566.5% | $4.3M-62.8% | -$3.3M-657.2% | $7.1M-38.3% | $6.2M+17.7% | $11.7M+51.0% | $589K+100.5% | $11.5M+117.1% |
| Net Income | $108.6M+299.7% | $22.3M+106.8% | $30.9M-44.7% | $26.8M-18.7% | $27.2M+66.3% | -$327.3M-680.4% | $55.9M+240.7% | $33.0M+550.3% |
| EPS (Basic) | $1.98+296.0% | $0.41+106.8% | $0.56-45.6% | $0.49-19.7% | $0.50+66.7% | -$6.01-670.5% | $1.03+232.3% | $0.61+535.7% |
| EPS (Diluted) | $1.93+286.0% | $0.40+106.7% | $0.56-45.6% | $0.49-18.3% | $0.50+66.7% | -$6.01-670.5% | $1.03+243.3% | $0.60+528.6% |
| Diluted Shares (Avg) | 56M+2.9% | 56M+2.8% | N/A | 55M+1.0% | 55M+0.2% | 54M+0.8% | N/A | 55M+1.1% |
LIVN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B+5.4% | $2.5B-1.7% | $2.6B+4.0% | $2.6B+1.4% | $2.5B+2.2% | $2.6B+4.0% | $2.5B+3.2% | $2.5B+8.3% |
| Current Assets | $1.0B-3.9% | $1.0B-13.4% | $1.1B-2.3% | $1.1B+0.4% | $1.1B+1.9% | $1.2B+12.6% | $1.1B+14.1% | $1.1B+14.6% |
| Cash & Equivalents | $516.6M-13.0% | $539.7M-26.9% | $635.6M+48.2% | $646.1M+86.5% | $593.6M+80.3% | $738.4M+138.8% | $428.9M+60.9% | $346.4M+48.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $172.6M+4.4% | $165.5M+7.5% | $164.7M+11.6% | $167.5M+3.3% | $165.3M+6.9% | $154.0M+0.5% | $147.6M-0.2% | $162.3M+0.4% |
| Accounts Receivable | $231.3M+5.0% | $229.3M+13.5% | $216.0M+11.8% | $211.6M+7.3% | $220.2M+9.6% | $202.1M-3.5% | $193.2M-10.2% | $197.2M+3.8% |
| Long-Term Investments | $15.3M | $18.5M | $20.3M-19.1% | $0 | $0 | $0 | $25.1M | $0 |
| Goodwill | $779.1M-1.8% | $785.6M+3.1% | $792.8M+5.7% | $791.0M+1.2% | $793.4M+3.5% | $761.9M-1.3% | $750.0M-4.2% | $781.6M+1.9% |
| Total Liabilities | $1.3B-4.9% | $1.3B-14.4% | $1.4B+18.5% | $1.4B+15.5% | $1.4B+14.3% | $1.5B+23.1% | $1.2B+3.0% | $1.2B+9.8% |
| Current Liabilities | $707.0M-14.5% | $762.5M+2.8% | $808.1M+106.1% | $827.6M+155.1% | $827.1M+173.0% | $741.6M+126.2% | $392.1M+17.1% | $324.4M+9.8% |
| Non-Current Liabilities | $608.5M+9.3% | $542.5M-30.7% | $598.0M-24.7% | $572.8M-35.5% | $556.8M-38.7% | $782.9M-14.0% | $794.0M-2.8% | $887.5M+9.8% |
| Long-Term Debt | $289.9M-16.8% | $285.2M-48.1% | $345.2M-37.2% | $349.0M-42.2% | $348.5M-42.4% | $549.2M-9.2% | $549.6M-3.3% | $604.3M+6.4% |
| Total Equity | $1.3B+18.0% | $1.2B+17.1% | $1.2B-9.1% | $1.2B-11.7% | $1.1B-9.6% | $1.0B-15.3% | $1.3B+3.3% | $1.3B+6.9% |
| Retained Earnings | -$1.0B+15.7% | -$1.1B+8.7% | -$1.1B-26.8% | -$1.2B-22.7% | -$1.2B-21.3% | -$1.2B-22.0% | -$903.3M+6.5% | -$959.1M+2.4% |
LIVN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $66.6M+5.8% | $15.2M-36.5% | $82.4M+4.7% | $85.1M+66.8% | $62.9M+45.1% | $24.0M+140.1% | $78.7M+45.9% | $51.0M+181.2% |
| Depreciation & Amortization | $15.4M+36.2% | $12.9M+21.0% | $12.1M+13.1% | $12.2M+15.7% | $11.3M+8.2% | $10.6M+0.4% | $10.7M+73.4% | $10.6M+61.8% |
| Stock-Based Compensation | $16.9M+84.0% | $8.3M+6.3% | N/A | $9.9M+16.2% | $9.2M+11.9% | $7.8M-23.9% | N/A | $8.6M |
| Capital Expenditures | $31.6M+108.3% | $14.3M+32.4% | $32.2M+209.8% | $22.9M+26.1% | $15.1M+24.6% | $10.8M+68.6% | $10.4M-19.5% | $18.1M+108.2% |
| Free Cash Flow | $35.0M-26.7% | $926K-93.0% | $50.2M-26.6% | $62.2M+89.3% | $47.8M+53.1% | $13.2M+267.7% | $68.3M+66.4% | $32.8M+248.8% |
| Investing Cash Flow | -$31.9M-255.9% | -$14.6M-37.2% | -$30.3M-182.6% | -$23.1M-24.5% | -$9.0M+28.6% | -$10.6M-67.0% | -$10.7M+11.8% | -$18.5M-84.2% |
| Financing Cash Flow | -$56.4M+73.0% | -$94.2M-2031.8% | -$62.9M-1725.9% | -$9.4M-185.6% | -$209.0M-1660.6% | -$4.4M-111.9% | -$3.4M+31.4% | -$3.3M+23.3% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
LIVN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.1%+2.3pp | 67.3%-1.0pp | 66.4%-0.2pp | 68.4%-1.0pp | 67.8%+0.3pp | 68.3%-0.6pp | 66.6%+10.3pp | 69.5%-1.1pp |
| Operating Margin | 12.7%-2.7pp | 11.5%-3.9pp | 11.8%+0.3pp | 15.1%+3.9pp | 15.4%+2.8pp | 15.3%+9.8pp | 11.5%+39.9pp | 11.2%+9.6pp |
| Net Margin | 27.8%+20.1pp | 6.2% | 8.6%-8.8pp | 7.5%-2.9pp | 7.7%+2.6pp | -103.3% | 17.4%+12.1pp | 10.4%+12.9pp |
| Return on Equity | 8.2%+5.8pp | 1.8%+33.5pp | 2.6%-1.7pp | 2.3%-0.2pp | 2.4%+1.1pp | -31.6%-28.2pp | 4.2%+2.9pp | 2.5%+3.1pp |
| Return on Assets | 4.1%+3.0pp | 0.9%+13.7pp | 1.2%-1.1pp | 1.1%-0.3pp | 1.1%+0.4pp | -12.8%-11.1pp | 2.2%+1.6pp | 1.3%+1.6pp |
| Current Ratio | 1.45+0.2x | 1.33-0.2x | 1.36-1.5x | 1.33-2.0x | 1.29-2.2x | 1.58-1.6x | 2.87-0.1x | 3.37+0.1x |
| Debt-to-Equity | 0.22-0.1x | 0.24-0.3x | 0.29-0.1x | 0.30-0.2x | 0.31-0.2x | 0.530.0x | 0.420.0x | 0.460.0x |
| Asset Turnover | 0.150.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.120.0x | 0.130.0x | 0.130.0x |
| FCF Margin | 9.0%-4.6pp | 0.3%-3.9pp | 13.9%-7.3pp | 17.4%+7.1pp | 13.6%+3.8pp | 4.2%+2.9pp | 21.2%+8.0pp | 10.3%+7.0pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| LivaNova PLC LIVN | FY2025 | $1.4B | -$242.5M | -17.5% | $4.2B | 59/100 |
| Integer Holdings Corporation ITGR | FY2025 | $1.9B | $102.8M | 5.5% | $4.3B | 58/100 |
| Haemonetics Corporation HAE | FY2026 | $1.3B | $97K | 0.0% | $4.6B | 58/100 |
| Inspire Medical Systems, Inc. INSP | FY2025 | $912.0M | $145.4M | 16.0% | $2.0B | 64/100 |
| Alphatec Holdings, Inc. ATEC | FY2025 | $764.2M | -$143.4M | -18.8% | $1.6B | 35/100 |
| QuidelOrtho Corporation QDEL | FY2025 | $2.7B | -$1.1B | -41.4% | $844.2M | 23/100 |
Where LivaNova PLC Ranks
Frequently Asked Questions
What is LivaNova PLC's annual revenue?
LivaNova PLC (LIVN) reported $1.4B in total revenue for fiscal year 2025. This represents a 10.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is LivaNova PLC's revenue growing?
LivaNova PLC (LIVN) revenue grew by 10.7% year-over-year, from $1.3B to $1.4B in fiscal year 2025.
Is LivaNova PLC profitable?
No, LivaNova PLC (LIVN) reported a net income of -$242.5M in fiscal year 2025, with a net profit margin of -17.5%.
What is LivaNova PLC's EBITDA?
LivaNova PLC (LIVN) had EBITDA of $245.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does LivaNova PLC have?
As of fiscal year 2025, LivaNova PLC (LIVN) had $635.6M in cash and equivalents against $345.2M in long-term debt.
What is LivaNova PLC's gross margin?
LivaNova PLC (LIVN) had a gross margin of 67.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is LivaNova PLC's operating margin?
LivaNova PLC (LIVN) had an operating margin of 14.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is LivaNova PLC's net profit margin?
LivaNova PLC (LIVN) had a net profit margin of -17.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is LivaNova PLC's return on equity (ROE)?
LivaNova PLC (LIVN) has a return on equity of -20.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is LivaNova PLC's free cash flow?
LivaNova PLC (LIVN) generated $173.3M in free cash flow during fiscal year 2025. This represents a 27.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is LivaNova PLC's operating cash flow?
LivaNova PLC (LIVN) generated $254.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are LivaNova PLC's total assets?
LivaNova PLC (LIVN) had $2.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are LivaNova PLC's capital expenditures?
LivaNova PLC (LIVN) invested $81.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does LivaNova PLC spend on research and development?
LivaNova PLC (LIVN) invested $185.8M in research and development during fiscal year 2025.
What is LivaNova PLC's current ratio?
LivaNova PLC (LIVN) had a current ratio of 1.36 as of fiscal year 2025, which is considered adequate.
What is LivaNova PLC's debt-to-equity ratio?
LivaNova PLC (LIVN) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is LivaNova PLC's return on assets (ROA)?
LivaNova PLC (LIVN) had a return on assets of -9.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is LivaNova PLC's P/E ratio?
LivaNova PLC (LIVN) trades at 22.1x earnings, its market capitalization divided by net income of $188.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $4.2B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is LivaNova PLC's price-to-sales ratio?
LivaNova PLC (LIVN) trades at 2.8x sales, its market capitalization divided by revenue of $1.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.2B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is LivaNova PLC's Altman Z-Score?
LivaNova PLC (LIVN) has an Altman Z-Score of 2.08, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is LivaNova PLC's Piotroski F-Score?
LivaNova PLC (LIVN) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are LivaNova PLC's earnings high quality?
LivaNova PLC (LIVN) reported a net loss of $242.5M while generating $254.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can LivaNova PLC cover its interest payments?
LivaNova PLC (LIVN) has an interest coverage ratio of 4.05x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is LivaNova PLC?
LivaNova PLC (LIVN) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.